Sunday, April 26, 2009

Live Coverage of Selectica v. Versata Poison Pill Dispute

Courtroom View Network (CVN) will provide a live and on demand video webcast of the landmark Selectica v. Versata trial beginning Monday, April 27 in the Delaware Court of Chancery.

At issue in the 5-day trial is the validity of the company's poison pill which was triggered after Selectica reduced the threshold from 15% to 5% and Versata, who owned 5.2% at the time, knowingly acquired more shares. Click here to review our earlier blog summarizing this. Also, click here to review a January 6 client alert from Schulte Roth & Zabel. (Marc Weingarten from SRZ is an expert on activist investing and a regular contributor to this blog).

In addition to the live webcast, CVN subscribers will have access to all trial content "on demand". Additionally, all evidence presented at trial will be included digitally as part of the webcast. Once the trial is underway we will post a link to a short video clip. In the meantime, click here to see a sample of the Hexion v. Huntsman trial covered by CVN.

To order the Selectica trial from CVN click here.

Posted by Damien Park, President & CEO Hedge Fund Solutions.